1. Huang, Chenshen, Zhu, Fengshuo, Zhang, Hao, Wang, Ning, Huang, Qi. 2023. Identification of S1PR4 as an immune modulator for favorable prognosis in HNSCC through machine learning. In iScience, 26, 107693. doi:10.1016/j.isci.2023.107693. https://pubmed.ncbi.nlm.nih.gov/37680482/
2. Mo, Xian-Gang, Liu, Wei, Yang, Yao, Chen, Bingbo, Cai, Yue. 2019. NCF2, MYO1F, S1PR4, and FCN1 as potential noninvasive diagnostic biomarkers in patients with obstructive coronary artery: A weighted gene co-expression network analysis. In Journal of cellular biochemistry, 120, 18219-18235. doi:10.1002/jcb.29128. https://pubmed.ncbi.nlm.nih.gov/31245869/
3. Höglund, Julia, Hadizadeh, Fatemeh, Ek, Weronica E, Karlsson, Torgny, Johansson, Åsa. 2022. Gene-Based Variant Analysis of Whole-Exome Sequencing in Relation to Eosinophil Count. In Frontiers in immunology, 13, 862255. doi:10.3389/fimmu.2022.862255. https://pubmed.ncbi.nlm.nih.gov/35935937/
4. Li, Wo, Liu, Jitong, Cai, Ting, Hu, Xia. 2024. TCF12 Transcriptionally Activates SPHK1 to Induce Osteosarcoma Angiogenesis by Promoting the S1P/S1PR4/STAT3 Axis. In Molecular and cellular biology, 44, 178-193. doi:10.1080/10985549.2024.2341781. https://pubmed.ncbi.nlm.nih.gov/38767243/
5. Olesch, Catherine, Sirait-Fischer, Evelyn, Berkefeld, Matthias, Brüne, Bernhard, Weigert, Andreas. . S1PR4 ablation reduces tumor growth and improves chemotherapy via CD8+ T cell expansion. In The Journal of clinical investigation, 130, 5461-5476. doi:10.1172/JCI136928. https://pubmed.ncbi.nlm.nih.gov/32663191/
智鼠故事 
